Abstract
BACKGROUND
Approximately 40% of people aged ≥ 65 experience memory loss, particularly in episodic memory. Identifying the genetic basis of episodic memory decline is crucial for uncovering its underlying causes.
METHODS
We investigated common and rare genetic variants associated with episodic memory decline in 742 (632 for rare variants) Ashkenazi Jewish individuals (mean age 75) from the LonGenity study. All-atom molecular dynamics simulations were performed to uncover mechanistic insights underlying rare variants associated with episodic memory decline.
RESULTS
In addition to the common polygenic risk of Alzheimer’s disease, we identified and replicated rare variant associations in ITSN1 and CRHR2. Structural analyses revealed distinct memory pathologies mediated by interfacial rare coding variants such as impaired receptor activation of corticotropin releasing hormone and dysregulated L-serine synthesis.
DISCUSSION
Our study uncovers novel risk loci for episodic memory decline. The identified underlying mechanisms point toward heterogenous memory pathologies mediated by rare coding variants.
Highlights
We demonstrated the contribution of the common polygenic risk of Alzheimer’s disease to episodic memory decline.
We discovered and replicated two risk genes associated with episodic memory decline implicated by rare variants, were discovered and replicated.
We demonstrated molecular mechanisms and potential novel memory pathologies underlying interfacial rare coding variants.
Molecular dynamics simulations were performed to understand the downstream effects of risk rare coding variants.
If you do not see content above, kindly GO TO SOURCE.
Not all publishers encode content in a way that enables republishing at Neuro.vip.
This post is Copyright: Amanat Ali,
Sofiya Milman,
Erica F. Weiss,
Tina Gao,
Valerio Napolioni,
Nir Barzilai,
Zhengdong D. Zhang,
Jhih‐Rong Lin | November 19, 2024